Showing 20 of 203 recruiting trials for “combined-hepatocellular-carcinoma-and-cholangiocarcinoma”
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
👨⚕️ Jason Molitoris, MD, PhD, University of Maryland Medical Center / Maryland Proton Treatment Center📍 2 sites📅 Started Oct 2024View details ↗
Needle-based Percutaneous Ablation of Liver Tumors.
Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation
👨⚕️ Francesco Vasuri, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Oct 2024View details ↗
Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
RecruitingNCT06569498 ↗
Neoadjuvant Triple Therapy for Resectable HCC
RecruitingNCT06602011 ↗
Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
RecruitingNCT06648057 ↗
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE
🏥 The First Affiliated Hospital with Nanjing Medical University📍 4 sites📅 Started Sep 2024View details ↗
RecruitingNCT06777628 ↗
Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma
👨⚕️ Laura Gramantieri, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Sep 2024View details ↗
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
RecruitingNCT06718257 ↗
Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma
👨⚕️ Weilin Wang, PHD, Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Sep 2024View details ↗
Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
RecruitingNCT07101237 ↗
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
RecruitingNCT07303712 ↗
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Phase 2 Study of WGI-0301 for Advanced HCC
RecruitingNCT07291063 ↗
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →